Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2015 Feb 10

PMID 25663241

Citations 2

Authors

Fasiha Kanwal

Donna L White

Li Jiao

Shahriar Tavakoli-Tabasi

Shubhada Sansgiry

David J Ramsey

Jill Kuzniarek

Andrew Spiegelman

Hashem B El-Serag

Affiliations

Soon will be listed here.

Abstract

Background: Few studies have shown that host interleukin-28B (IL28B) genetic polymorphisms are associated with insulin resistance in patients with chronic hepatitis C virus (HCV) infection. However, the clinical relevance of this relationship is unclear.

Aims: We examined the association between IL28B genotype for rs12980275 and risk of type 2 diabetes and diabetes-related complications.

Methods: We used a cross-sectional study of prospectively recruited male veterans with chronic HCV. We employed logistic regression analysis and adjusted for patients' age, race, body mass index, and hepatic fibrosis.

Results: A total of 528 participants were recruited (mean age 59.1 years; 38.5 % African-American; 40.3 % advanced fibrosis). Of these, 36.1 % were homozygous for favorable AA allele for rs12980275, 49.0 % were heterozygous (AG), and 14.0 % were homozygous for the unfavorable allele (GG). Prevalence of diabetes was significantly lower in patients with both favorable alleles (AA) than that with at least one unfavorable IL28B G allele (21.1 vs. 30.2 %, p = 0.02). Similarly, patients who were homozygous for the favorable alleles had lower prevalence of diabetes-related complications than patients with any unfavorable IL28B allele (5.7 vs. 12.2 %, p = 0.01). This association did not change after adjusting for sociodemographic characteristics, body mass index, and stage of hepatic fibrosis (adjusted ORdiabetes 0.56, 95 % CI 0.35-0.89; ORdiabetes-related complications 0.47, 95 % CI 0.23-0.96).

Conclusions: Patients who have favorable AA IL28B alleles have a lower prevalence of diabetes and related complications compared with patients with unfavorable IL28B rs12980275 genotype. IL28B genotype information may be used to counsel HCV patients regarding their individualized risk of diabetes and diabetes-related complications.

Citing Articles

Association of Overt Diabetes Mellitus with the Non-CC but not the CC Genotype of Interleukin-28B in Hepatitis C Virus Infected Patients.

Kumar A, Gupta V, Sharma P, Bansal N, Singla V, Arora A J Clin Transl Hepatol. 2016; 4(1):26-31.

PMID: 27047769 PMC: 4807140. DOI: 10.14218/JCTH.2016.00040.

Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.

El-Serag H, Kanwal F, Richardson P, Kramer J Hepatology. 2016; 64(1):130-7.

PMID: 26946190 PMC: 4917456. DOI: 10.1002/hep.28535.

References

Ascaso J, Romero P, Real J, Priego A, Valdecabres C, Carmena R . [Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population]. Med Clin (Barc). 2001; 117(14):530-3. DOI: 10.1016/s0025-7753(01)72168-9. View

Lasfar A, Abushahba W, Balan M, Cohen-Solal K . Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol. 2011; 2011:349575. PMC: 3235441. DOI: 10.1155/2011/349575. View

White D, Ratziu V, El-Serag H . Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008; 49(5):831-44. PMC: 2642971. DOI: 10.1016/j.jhep.2008.08.006. View

Medici G, Mussi C, Fantuzzi A, Malavolti M, Albertazzi A, Bedogni G . Accuracy of eight-polar bioelectrical impedance analysis for the assessment of total and appendicular body composition in peritoneal dialysis patients. Eur J Clin Nutr. 2005; 59(8):932-7. DOI: 10.1038/sj.ejcn.1602165. View

Stattermayer A, Rutter K, Beinhardt S, Scherzer T, Stadlmayr A, Hofer H . Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C. J Hepatol. 2012; 57(3):492-8. DOI: 10.1016/j.jhep.2012.04.036. View

Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers R, Thabut D . Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol. 2004; 3(1):8. PMC: 522750. DOI: 10.1186/1476-5926-3-8. View

Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate M . IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009; 41(10):1100-4. DOI: 10.1038/ng.447. View

Halfon P, Munteanu M, Poynard T . FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol. 2008; 32(6 Suppl 1):22-39. DOI: 10.1016/S0399-8320(08)73991-5. View

Noureddin M, Wright E, Alter H, Clark S, Thomas E, Chen R . Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology. 2013; 58(5):1548-57. PMC: 3758382. DOI: 10.1002/hep.26506. View

10.

Sato M, Kondo M, Tateishi R, Fujiwara N, Kato N, Yoshida H . Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis. PLoS One. 2014; 9(3):e91822. PMC: 3956722. DOI: 10.1371/journal.pone.0091822. View

11.

Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N . Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009; 41(10):1105-9. DOI: 10.1038/ng.449. View

12.

Monzillo L, Hamdy O . Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev. 2004; 61(12):397-412. DOI: 10.1301/nr.2003.dec.397-412. View

13.

Petta S, Rosso C, Leung R, Abate M, Booth D, Salomone F . Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C. Clin Gastroenterol Hepatol. 2012; 11(3):311-7.e1. DOI: 10.1016/j.cgh.2012.11.022. View

14.

Malavolti M, Mussi C, Poli M, Fantuzzi A, SALVIOLI G, Battistini N . Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol. 2003; 30(4):380-91. DOI: 10.1080/0301446031000095211. View

15.

Li M, Liu X, Zhou Y, Su S . Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses. J Leukoc Biol. 2009; 86(1):23-32. DOI: 10.1189/jlb.1208761. View

16.

Rauch A, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T . Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology. 2010; 138(4):1338-45, 1345.e1-7. DOI: 10.1053/j.gastro.2009.12.056. View

17.

White D, Tavakoli-Tabasi S, Kuzniarek J, Pascua R, Ramsey D, El-Serag H . Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2011; 55(3):759-68. PMC: 3399504. DOI: 10.1002/hep.24618. View

18.

Ge D, Fellay J, Thompson A, Simon J, Shianna K, Urban T . Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461(7262):399-401. DOI: 10.1038/nature08309. View

19.

Veldt B, Duarte-Rojo A, Thompson A, Watt K, Heimbach J, Tillmann H . Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C. Am J Transplant. 2012; 12(3):737-44. DOI: 10.1111/j.1600-6143.2011.03843.x. View